European Medicines Agency (EMA) is advising marketing authorisation holders to submit type IA and type IAIN variations for 2024 no later than 30th November, 2024. This will enable EMA to acknowledge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback